LUTONIX 035 DRUG COATED BALLOON PTA CATHETER

Drug-eluting Peripheral Transluminal Angioplasty Catheter

FDA Premarket Approval P130024 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for lutonix dcb is indicated for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo, restenotic, or in-stent restenotic lesions up to 300 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-7 mm.

DeviceLUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Classification NameDrug-eluting Peripheral Transluminal Angioplasty Catheter
Generic NameDrug-eluting Peripheral Transluminal Angioplasty Catheter
ApplicantLUTONIX
Date Received2016-01-04
Decision Date2017-02-07
Notice Date2017-02-15
PMAP130024
SupplementS009
Product CodeONU
Docket Number17M-0831
Advisory CommitteeCardiovascular
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product Yes
Applicant Address LUTONIX 9409 Science Center Dr new Hope, MN 55428
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P130024Original Filing
S042 2021-11-18 30-day Notice
S041 2021-07-06 30-day Notice
S040 2021-03-08 Real-time Process
S039
S038
S037 2020-09-30 Real-time Process
S036 2020-04-13 30-day Notice
S035
S034
S033 2019-11-29 Real-time Process
S032 2019-11-25 30-day Notice
S031
S030 2019-09-20 Normal 180 Day Track
S029 2019-09-03 Special (immediate Track)
S028
S027 2019-02-26 Real-time Process
S026 2018-11-16 Real-time Process
S025 2018-10-04 Real-time Process
S024 2018-06-25 Real-time Process
S023 2018-06-20 30-day Notice
S022 2018-01-25 Normal 180 Day Track
S021 2017-12-08 Normal 180 Day Track No User Fee
S020 2017-09-25 Normal 180 Day Track No User Fee
S019
S018 2017-02-06 30-day Notice
S017 2016-11-28 30-day Notice
S016
S015 2016-08-15 Normal 180 Day Track No User Fee
S014 2016-07-05 Normal 180 Day Track
S013 2016-06-15 Normal 180 Day Track No User Fee
S012 2016-04-29 Special (immediate Track)
S011 2016-03-25 Normal 180 Day Track No User Fee
S010 2016-01-27 Real-time Process
S009 2016-01-04 Panel Track
S008 2015-11-09 Special (immediate Track)
S007 2015-08-07 Special (immediate Track)
S006 2015-07-13 Normal 180 Day Track No User Fee
S005 2015-06-02 Normal 180 Day Track
S004 2015-03-02 Real-time Process
S003 2015-02-25 135 Review Track For 30-day Notice
S002 2015-01-12 Normal 180 Day Track
S001 2014-11-24 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.